Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Feb 23;7(1):e02228-15.
doi: 10.1128/mBio.02228-15.

Generic Statins and Angiotensin Receptor Blockers: Are They Really Useful in Ebola?

Viroj Wiwanitkit  1
Affiliations
Comment

Generic Statins and Angiotensin Receptor Blockers: Are They Really Useful in Ebola?

Viroj Wiwanitkit. mBio. .
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

    1. Fedson DS, Jacobson JR, Rordam OM, Opal SM. 2015. Treating the host response to Ebola virus disease with generic statins and angiotensin receptor blockers. mBio 6:e00716-15. doi:10.1128/mBio.00716-15. - DOI - PMC - PubMed
    1. Wouters CW, Wever KE, Bronckers I, Hopman MT, Smits P, Thijssen DH, Rongen GA. 2012. Short-term statin treatment does not prevent ischemia and reperfusion-induced endothelial dysfunction in humans. J Cardiovasc Pharmacol 59:22–28. doi:10.1097/FJC.0b013e318232b1a4. - DOI - PubMed
    1. Baskerville A, Fisher-Hoch SP, Neild GH, Dowsett AB. 1985. Ultrastructural pathology of experimental Ebola haemorrhagic fever virus infection. J Pathol 147:199–209. doi:10.1002/path.1711470308. - DOI - PubMed
    1. Sanchez A, Lukwiya M, Bausch D, Mahanty S, Sanchez AJ, Wagoner KD, Rollin PE. 2004. Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels. J Virol 78:10370–10377. doi:10.1128/JVI.78.19.10370-10377.2004. - DOI - PMC - PubMed
    1. Yahiro E, Miura S, Suematsu Y, Matsuo Y, Arimura T, Kuwano T, Imaizumi S, Iwata A, Uehara Y, Saku K. 2015. Addition of a nitric oxide donor to an angiotensin II type 1 receptor blocker may cancel its blood pressure-lowering effects. Int Heart J 56:656–660. doi:10.1536/ihj.15-200. - DOI - PubMed

MeSH terms

Substances

LinkOut - more resources